{"type":"trials","record":{"id":41482,"source_id":"clinicaltrials-gov","external_id":"NCT03690505","title":"Assessment of the Knowledge and Needs of Patients With AMD Before a Therapeutic Patient Education Program is Put in Place","brief_summary":"Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for \"straight-ahead\" activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail The purpose of the study is to describe in patients with AMD and depending on the nature of their pathology (neovascular or atrophic): (i) knowledge about their pathology (risk factors, symptoms, treatments, self-monitoring tool), (ii) their needs and (iii) impact on their daily lives This study is to make an inventory of the knowledge of patients with AMD about their disease and risk factors using a questionnaire (Appendix 1) and to identify their needs, the impact of the disease on their daily lives during individual interviews by raising the recurrent data and confronting them during the focus group. The information gathered will enable the construction of a therapeutic education program for better patient care and to strengthen the patient's capacities so that he becomes an actor in his change throughout his care project. This a 3 steps study: 1. 200 patients will be enrolled and answer a questionnaire on knowledge of the disease 2. Two groups of 20 patients will be selected to participate to a semi-structured individual interviews 3. Two focus groups of 10 patients will be organized to assess needs, expectations, satisfactions or to better understand opinions, motivations or behaviors.","overall_status":"Completed","phases":[],"study_type":"INTERVENTIONAL","sponsor":"University Hospital, Limoges","enrollment":118,"countries":["France"],"start_date":"2019-03-12","completion_date":"2023-01-04","last_update_date":"2026-06-24","source_url":"https://clinicaltrials.gov/study/NCT03690505","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:25:30.378222+00:00","last_seen_at":"2026-09-25T06:20:47.789+00:00","metadata":{"sex":"ALL","acronym":"DEMELE","age_range":"50 Months","comparator":null,"organization":"University Hospital, Limoges","interventions":["Interviews"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Knowledge of AMD — throughout the study, 2 years at maximum","Social vulnerability — throughout the study, 2 years at maximum","Health literacy. — throughout the study, 2 years at maximum"],"design_description":"NA · SINGLE GROUP · SUPPORTIVE CARE · NONE","source_has_results":false},"controlled_terms":["Age-related Macular Degeneration (AMD)","Interviews"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":100,"publication_state":"published","match_explanation":"Abstract contains controlled term: age-related macular degeneration.","quality_checked_at":"2026-09-25T06:20:59.355028+00:00","duplicate_cluster_key":"id:nct03690505","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2019-03-12 to 2023-01-04","comparator":null,"confidence":"structured-source","population":"ALL · 50 Months","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:20:47.820Z","intervention":["Interviews"],"participants":118,"study_design":"NA · SINGLE GROUP · SUPPORTIVE CARE · NONE","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Knowledge of AMD — throughout the study, 2 years at maximum","Social vulnerability — throughout the study, 2 years at maximum","Health literacy. — throughout the study, 2 years at maximum"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"vision-aging","is_published":true,"match_reasons":["Abstract contains controlled term: age-related macular degeneration.","Source terminology contains: age-related macular degeneration.","Abstract supplies longevity context: age-related.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["abstract","controlled terminology","abstract context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Vision ageing","slug":"vision-aging"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/41482","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}